March 20, 2025 - 10:26

Avalo Therapeutics has announced its financial results for 2024, highlighting significant updates regarding its ongoing clinical trials and organizational changes. The company is eagerly anticipating topline data from the Phase 2 LOTUS Trial of AVTX-009, which is being investigated for the treatment of hidradenitis suppurativa. This crucial data is expected to be released in 2026, marking an important milestone in Avalo's research and development efforts.
In a strategic move to bolster its leadership team, Avalo has appointed Jennifer Riley as the Chief Strategy Officer. Her expertise is expected to enhance the company's strategic direction as it navigates the complex landscape of biotechnology.
As of December 31, 2024, Avalo reported having approximately $135 million in cash reserves. This financial position is projected to provide sufficient runway into at least 2027, allowing the company to continue its focus on advancing innovative treatments for immune dysregulation.
December 14, 2025 - 05:49
G.I.F.T. Initiative Supports Black-Owned Businesses in Holiday MarketThe G.I.F.T. initiative, which stands for Generating Income for Tomorrow`s Goal, is making waves in Kansas City by spotlighting Black-owned businesses during the holiday market season. This...
December 13, 2025 - 01:25
SBA Offices in Los Angeles Area Set to Close, Assistance Still Available for Fire-Affected ResidentsThe Small Business Administration is set to close its two offices located in the Los Angeles area, specifically in the Palisades and Eaton fire zones, next week. This decision comes as the agency...
December 12, 2025 - 04:26
SpaceX's Ambitious IPO Could Transform Texas EconomySpaceX, the Elon Musk-owned aerospace company, is planning to go public next year with a potential $1.5 trillion IPO, which would set a new record for a public offering and have a significant...
December 11, 2025 - 02:18
The Rising Popularity of Asset-Based Lending Among Business LeadersIn today`s dynamic financial landscape, an increasing number of business leaders are exploring asset-based lending as a viable solution for enhancing liquidity and flexibility. Traditional cash...